Search Results 561-570 of 18151 for sterility

1. A Study to Assess the Effectiveness and Safety of Rilonacept Treatment in Subjects with Recurrent Pericarditis - Mayo Clinic

   Female subjects must be postmenopausal, or incapable of pregnancy or permanently sterile, or if of childbearing potential must agree to use highly-effective ...

2. AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

   Women of childbearing potential (e.g., not post-menopausal for at least one year or surgically sterile) must agree to use an acceptable birth control method ...

3. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

   Women of non-childbearing potential may be included if they are either surgically sterile or have been postmenopausal for ≥1 year. Fertile men must also ...

4. Stress Management for Couples Undergoing In Vitro Fertilization (IVF) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Female patients: if they are of childbearing potential (except if postmenopausal for at least 1 year before the screening visit, OR are surgically sterile), ...

6. Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma - Mayo Clinic

   NOTE: Females are considered of child bearing potential unless they are surgically sterile (have undergone a hysterectomy, bilateral tubal ligation, or ...

7. New Technology Used by Mayo Clinic Treats Evaporative Dry Eye Symptoms

   An FDA-approved, patented, single-use sterile device resembling an eyecup is placed over the eye while the patient reclines. During a 12-minute period, the ...

8. Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure - Mayo Clinic

   Surgically sterile (bilateral tubal ligation, hysterectomy, bilateral oophorectomy) 6 months minimum prior to IP administration; Intrauterine device in place ...

9. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... sterile, or abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication; Male participants should ...

10. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

    Women who are not of childbearing potential and who are considered to be postmenopausal (≥ 12 months of non-therapy amenorrhea) or surgically sterile ...